Listen
Reason for request
Inclusion on list of products for hospital use.
-
Actual benefit
| Important |
The actual benefit of ACTILYSE 2 mg is substantial. |
Improvement in actual benefit
| IV (mineur) |
ACTILYSE 2 mg provides a minor improvement in actual benefit (IAB IV) in terms of efficacy in comparison with ACTOSOLV UROKINASE. |
English version
Contact Us
Évaluation des médicaments
Français